3.25
price up icon0.31%   0.02
 
loading
Schlusskurs vom Vortag:
$3.23
Offen:
$3.27
24-Stunden-Volumen:
41,945
Relative Volume:
0.57
Marktkapitalisierung:
$1.15B
Einnahmen:
$842.96M
Nettoeinkommen (Verlust:
$-185.63M
KGV:
-6.1799
EPS:
-0.5259
Netto-Cashflow:
$-228.52M
1W Leistung:
-2.41%
1M Leistung:
-23.04%
6M Leistung:
-3.57%
1J Leistung:
-57.65%
1-Tages-Spanne:
Value
$3.2235
$3.31
1-Wochen-Bereich:
Value
$3.1601
$3.37
52-Wochen-Spanne:
Value
$2.85
$7.98

Evotec Se Adr Stock (EVO) Company Profile

Name
Firmenname
Evotec Se Adr
Name
Telefon
-
Name
Adresse
-
Name
Mitarbeiter
0
Name
Twitter
Name
Nächster Verdiensttermin
2024-11-06
Name
Neueste SEC-Einreichungen
Name
EVO's Discussions on Twitter

Vergleichen Sie EVO mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Drug Manufacturers - Specialty & Generic icon
EVO
Evotec Se Adr
3.24 1.15B 842.96M -185.63M -228.52M -0.5259
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
159.99 73.88B 9.26B 2.49B 2.30B 5.47
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
15.18 48.17B 30.25B 1.37B 5.08B 0.4257
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
10.46 47.59B 14.35B 1.85B 0 0.4023
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
14.81 17.28B 16.54B -1.64B 749.00M -1.45
Drug Manufacturers - Specialty & Generic icon
UTHR
United Therapeutics Corp
307.32 13.78B 2.76B 1.11B 898.10M 22.77

Evotec Se Adr Stock (EVO) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2024-10-07 Herabstufung Jefferies Buy → Hold
2024-08-08 Herabstufung Deutsche Bank Hold → Sell
2024-07-29 Herabstufung Morgan Stanley Overweight → Equal-Weight
2024-07-11 Herabstufung Deutsche Bank Buy → Hold
2024-04-12 Hochstufung Deutsche Bank Hold → Buy
2024-01-18 Hochstufung RBC Capital Mkts Sector Perform → Outperform
2023-06-23 Hochstufung Morgan Stanley Equal-Weight → Overweight
2023-06-16 Herabstufung BofA Securities Buy → Neutral
2023-06-08 Hochstufung Citigroup Neutral → Buy
2023-04-04 Hochstufung Morgan Stanley Underweight → Equal-Weight
2022-12-09 Eingeleitet H.C. Wainwright Buy
2022-11-16 Herabstufung Deutsche Bank Buy → Hold
2022-08-10 Herabstufung Morgan Stanley Overweight → Underweight
2022-03-02 Fortgesetzt Cowen Outperform
2022-01-07 Fortgesetzt Citigroup Neutral
Alle ansehen

Evotec Se Adr Aktie (EVO) Neueste Nachrichten

pulisher
Dec 29, 2024

Evotec: Some Recovery Has Come, But Much More Is Expected - Seeking Alpha

Dec 29, 2024
pulisher
Dec 27, 2024

Evotec shares surge 20% on Halozyme's 2 billion euro takeover bid - MSN

Dec 27, 2024
pulisher
Dec 10, 2024

In-Vitro Toxicology Testing Market Projected to Reach USD 30.06 Bn by 2033 - GlobeNewswire Inc.

Dec 10, 2024
pulisher
Nov 25, 2024

Markets Brief: Are Bank Stocks Expensive? - Morningstar

Nov 25, 2024
pulisher
Nov 23, 2024

Evotec SE withdraws acquisition offer By Investing.com - Investing.com South Africa

Nov 23, 2024
pulisher
Nov 22, 2024

Evotec SE withdraws acquisition offer - Investing.com India

Nov 22, 2024
pulisher
Nov 22, 2024

Halozyme ends bid to acquire Evotec at €2 billion valuation - Investing.com

Nov 22, 2024
pulisher
Nov 18, 2024

Halozyme outlines plan to acquire Evotec for €2 billion - Investing.com

Nov 18, 2024
pulisher
Nov 18, 2024

Halozyme outlines plan to acquire Evotec for €2 billion By Investing.com - Investing.com UK

Nov 18, 2024
pulisher
Nov 17, 2024

Halozyme to Fund Proposed Evotec Takeover in Cash, CEO Says - Yahoo Finance

Nov 17, 2024
pulisher
Nov 15, 2024

Evotec SE responds to media speculation - Investing.com India

Nov 15, 2024
pulisher
Nov 15, 2024

Large Pharma Partner Halozyme Therapeutics Offers To Acquire Germany-Based Evotec For ~$2 Billion - AOL

Nov 15, 2024
pulisher
Nov 15, 2024

Halozyme Therapeutics sinks after confirming $2B Evotec buyout offer - Seeking Alpha

Nov 15, 2024
pulisher
Nov 15, 2024

Evotec SE responds to media speculation By Investing.com - Investing.com UK

Nov 15, 2024
pulisher
Nov 14, 2024

Halozyme proposes $2 billion acquisition of Evotec - Investing.com India

Nov 14, 2024
pulisher
Nov 08, 2024

Earnings call: Evotec SE maintains 2024 outlook amid strategic changes - Investing.com India

Nov 08, 2024
pulisher
Nov 07, 2024

Evotec SE ADR earnings beat by $0.02, revenue fell short of estimates - Investing.com

Nov 07, 2024
pulisher
Nov 07, 2024

Evotec Reports Strategic Growth Amidst Revenue Challenges - TipRanks

Nov 07, 2024
pulisher
Nov 05, 2024

Evotec SE Reports 9M 2024 Results: Strategic Progress and Successful Expansion Amid Challenging Market Conditions - Yahoo Finance

Nov 05, 2024
pulisher
Oct 07, 2024

Evotec stock outlook clouded by strategy update delays, warns Jefferies - Investing.com

Oct 07, 2024
pulisher
Sep 23, 2024

KZIAKazia Therapeutics Limited American Depositary Shares Latest Stock News & Market Updates - StockTitan

Sep 23, 2024
pulisher
Aug 23, 2024

Stock Information - Evotec

Aug 23, 2024
pulisher
Aug 23, 2024

Annual General Meeting - Evotec

Aug 23, 2024
pulisher
Aug 23, 2024

Investor Relations - Evotec

Aug 23, 2024
pulisher
Aug 14, 2024

Bristol Myers' German Partner Evotec Plans Layoffs, Cites 'Challenging Revenues, Profitability' - Yahoo Finance

Aug 14, 2024
pulisher
Aug 13, 2024

Dozens of US Stocks Are Newly Undervalued After Market Selloff - Morningstar

Aug 13, 2024
pulisher
Aug 07, 2024

Evotec shares crash 36% on profit warning - Investing.com

Aug 07, 2024
pulisher
May 23, 2024

Earnings call: Evotec SE Q1 2024 results show mixed performance amid challenges - Investing.com

May 23, 2024
pulisher
Apr 08, 2024

T. Rowe Price Raises Stake in Evotec SE - TipRanks

Apr 08, 2024
pulisher
Jan 21, 2012

Together for Medicines That MatterEvotec - Evotec

Jan 21, 2012
pulisher
May 11, 2010

Evotech and Roche subsidiary Genentech enter into drug discovery alliance - Proactive Investors USA

May 11, 2010
pulisher
Sep 09, 2009

Evotec and Biogen Idec in research agreement - Proactive financial news

Sep 09, 2009

Finanzdaten der Evotec Se Adr-Aktie (EVO)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$9.735
price down icon 9.70%
$31.69
price down icon 2.97%
$95.31
price down icon 2.00%
$8.525
price down icon 0.93%
$105.98
price down icon 1.57%
$307.16
price down icon 1.34%
Kapitalisierung:     |  Volumen (24h):